Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia and the UK for a new...

Related Keywords

United Kingdom , Australia , Australian , Leslie Chong , Imugene Ltd , Vaxx Phase ,